SCHEMBL7030147

SCHEMBL7030147

CCNS(=O)(=O)c1ccc2c(c1)C(=O)c1ccc(S(=O)(=O)NCC)cc1C2=O

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.60
▸ PKM P14618 4/20 0.60
▸ GAA P10253 1/20 0.60
▸ KMT2A Q03164 3/20 0.59
▸ MEN1 O00255 2/20 0.59
▸ POLB P06746 1/20 0.59
▸ TSHR P16473 1/20 0.59
▸ APEX1 P27695 1/20 0.58
▸ PARG Q86W56 6/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ MAPT P10636 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ VCAM1 P19320 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ CA1 P00915 1/20 0.49
▸ CA2 P00918 1/20 0.49
▸ CA9 Q16790 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29902418 0.82 PKM (0.71) ALDH1A1PKMGAAKMT2AMEN1
SCHEMBL29902387 0.81 ALDH1A1 (0.59) ALDH1A1PKMGAAKMT2AMEN1
SCHEMBL20202316 0.80 ALDH1A1 (0.72) ALDH1A1PKMGAAKMT2AMEN1
SCHEMBL11511836 0.80 ALDH1A1 (0.83) ALDH1A1KMT2ATSHRSMN1; SMN2MAPK1
SCHEMBL11202734 0.79 PKM (0.61) ALDH1A1PKMGAAKMT2AMEN1
SCHEMBL11204500 0.79 PKM (0.61) ALDH1A1PKMGAAKMT2AMEN1
SCHEMBL13159565 0.79 PKM (0.93) ALDH1A1PKMGAAKMT2AMEN1
SCHEMBL13183051 0.79 PARG (0.59) ALDH1A1PKMGAAKMT2AMEN1
SCHEMBL13159473 0.78 ALDH1A1 (0.94) ALDH1A1PKMGAAKMT2AMEN1
SCHEMBL11321975 0.77 PKM (0.59) ALDH1A1PKMGAAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0833626-B1 MONO- AND DISULFO-SUBSTITUTED ANTHRAQUINONES AND THEIR USE FOR THE TREATMENT OF BONE MATRIX DISORDERS H GEN B V (NL) 2003-03-05 — — EP claimed
US-5856358-A PREVENT BONE EROSION BOONVILLE LIMITED (VG) 1999-01-05 — — US claimed
EP-0833626-B1 MONO- AND DISULFO-SUBSTITUTED ANTHRAQUINONES AND THEIR USE FOR THE TREATMENT OF BONE MATRIX DISORDERS H GEN B V (NL) 2003-03-05 — — EP disclosed
US-5856358-A PREVENT BONE EROSION BOONVILLE LIMITED (VG) 1999-01-05 — — US disclosed
EP-0833626-A1 MONO- AND DISULFO-SUBSTITUTED ANTHRAQUINONES AND THEIR USE FOR THE TREATMENT OF BONE MATRIX DISORDERS Boonville Limited (VG) 1998-04-08 — — EP disclosed
WO-1997000675-A1 MONO- AND DISULFO-SUBSTITUTED ANTHRAQUINONES AND THEIR USE FOR THE TREATMENT OF BONE MATRIX DISORDERS BOONVILLE LIMITED (VG) 1997-01-09 — — WO disclosed
Send feedback